Literature DB >> 12393861

Enamelysin (matrix metalloproteinase 20)-deficient mice display an amelogenesis imperfecta phenotype.

John J Caterina1, Ziedonis Skobe, Joanne Shi, Yanli Ding, James P Simmer, Henning Birkedal-Hansen, John D Bartlett.   

Abstract

Enamelysin is a tooth-specific matrix metalloproteinase that is expressed during the early through middle stages of enamel development. The enamel matrix proteins amelogenin, ameloblastin, and enamelin are also expressed during this same approximate developmental time period, suggesting that enamelysin may play a role in their hydrolysis. In support of this interpretation, recombinant enamelysin was previously demonstrated to cleave recombinant amelogenin at virtually all of the precise sites known to occur in vivo. Thus, enamelysin is likely an important amelogenin-processing enzyme. To characterize the in vivo biological role of enamelysin during tooth development, we generated an enamelysin-deficient mouse by gene targeting. Although mice heterozygous for the mutation have no apparent phenotype, the enamelysin null mouse has a severe and profound tooth phenotype. Specifically, the null mouse does not process amelogenin properly, possesses an altered enamel matrix and rod pattern, has hypoplastic enamel that delaminates from the dentin, and has a deteriorating enamel organ morphology as development progresses. Our findings demonstrate that enamelysin activity is essential for proper enamel development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393861     DOI: 10.1074/jbc.M209100200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  96 in total

1.  Altered ion-responsive gene expression in Mmp20 null mice.

Authors:  C E Tye; R Sharma; C E Smith; J D Bartlett
Journal:  J Dent Res       Date:  2010-10-07       Impact factor: 6.116

2.  Pseudogenization of the tooth gene enamelysin (MMP20) in the common ancestor of extant baleen whales.

Authors:  Robert W Meredith; John Gatesy; Joyce Cheng; Mark S Springer
Journal:  Proc Biol Sci       Date:  2010-09-22       Impact factor: 5.349

Review 3.  Matrix metalloproteinases and the regulation of tissue remodelling.

Authors:  Andrea Page-McCaw; Andrew J Ewald; Zena Werb
Journal:  Nat Rev Mol Cell Biol       Date:  2007-03       Impact factor: 94.444

Review 4.  MMPs as therapeutic targets--still a viable option?

Authors:  Barbara Fingleton
Journal:  Semin Cell Dev Biol       Date:  2007-07-06       Impact factor: 7.727

Review 5.  Biomimetic systems for hydroxyapatite mineralization inspired by bone and enamel.

Authors:  Liam C Palmer; Christina J Newcomb; Stuart R Kaltz; Erik D Spoerke; Samuel I Stupp
Journal:  Chem Rev       Date:  2008-11       Impact factor: 60.622

6.  Science is the fuel for the engine of technology and clinical practice.

Authors:  Malcolm L Snead; Harold C Slavkin
Journal:  J Am Dent Assoc       Date:  2009-09       Impact factor: 3.634

7.  Mmp-20 and Klk4 cleavage site preferences for amelogenin sequences.

Authors:  T Nagano; A Kakegawa; Y Yamakoshi; S Tsuchiya; J C-C Hu; K Gomi; T Arai; J D Bartlett; J P Simmer
Journal:  J Dent Res       Date:  2009-09       Impact factor: 6.116

8.  Enzymatic Processing of Amelogenin during Continuous Crystallization of Apatite.

Authors:  V Uskoković; M-K Kim; W Li; S Habelitz
Journal:  J Mater Res       Date:  2008-12       Impact factor: 3.089

9.  Amelogenin processing by MMP-20 prevents protein occlusion inside calcite crystals.

Authors:  Keith M Bromley; Rajamani Lakshminarayanan; Mitchell Thompson; Sowmya B Lokappa; Victoria A Gallon; Kang R Cho; S Roger Qiu; Janet Moradian-Oldak
Journal:  Cryst Growth Des       Date:  2012-08-23       Impact factor: 4.076

10.  MMP20 hemopexin domain mutation in amelogenesis imperfecta.

Authors:  S-K Lee; F Seymen; H-Y Kang; K-E Lee; K Gencay; B Tuna; J-W Kim
Journal:  J Dent Res       Date:  2010-01       Impact factor: 6.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.